Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who understand the study and are able to sign a written consent form
- People who have had surgery for an intermediate to high-risk skin melanoma at a specific stage, with no sign of the disease remaining after surgery (confirm with trial site for exact staging details)
- People who are able to read and speak Dutch
- People who are willing and able to travel to the UMCG (the study hospital) for visits
- People who are willing to continue their normal daily habits and lifestyle throughout the study
Who may not be able to join:
- People who are currently receiving adjuvant (additional cancer) treatment at the same time as the study (treatment after the study period has ended is allowed)
- People with certain existing health conditions that could affect study results, such as type 2 diabetes, heart disease, kidney disease, or an autoimmune disease
- People with a significant or unstable gut-related condition, such as coeliac disease, inflammatory bowel disease, short bowel syndrome, or acute or chronic pancreatitis
- People who have had an ileostomy or colostomy (surgically created openings in the abdomen for waste removal)
- People who have used antibiotics in the three months before joining the study
- People who use prednisolone or other medications that suppress the immune system
- People who rely on tube feeding or similar assisted feeding methods
- People who are pregnant or breastfeeding
- People who are currently participating in another interventional research study at the same time
- People who are unable or unwilling to follow the study rules
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: G. A.P. Hospers, MD, PhD, University Medical Center Groningen
Phone: +31 50 361 2821
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of a high fiber prebiotic vegetable (WholeFiber) on fecal SCFA levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.